Steve Cunningham1, Ann McMurray. 1. Department of Respiratory and Sleep Medicine, Royal Hospital for Sick Children, Sciennes Road, Edinburgh, UK. steve.cunningham@nhs.net
Abstract
OBJECTIVES: To assess the potential effect of two guideline discharge oxygen saturation (SpO(2)) recommendations (≥90% and ≥94%) in recovering bronchiolitis. METHODS AND PATIENTS: Infants aged up to 18 months requiring therapeutic oxygen for SpO(2) (≤93%) had SpO(2) assessed in air every 2 h. Time from admission to re-establish feeding (>75% normal) and for SpO(2) to become stable for at least 4 h at ≥90% and ≥94% were noted. RESULTS: 68 infants, median age 14 weeks, were included. Feeding problems resolved at a median of 11 h (inter-quartile range, IQR 0-47). SpO(2) became stable for at least 4 h at 17 h (IQR 0-49) for ≥90% and 63 h (IQR 34-105) for ≥94%. Time for infants to achieve a stable SpO(2)≥90% and resolve feeding difficulties was a median of 22 h (IQR 7-39 h) sooner than the equivalent for stable SpO(2)≥94%. CONCLUSIONS: Accepting lower SpO(2) at discharge could significantly reduce length of stay, but require the clinical and safety effects to be studied.
OBJECTIVES: To assess the potential effect of two guideline discharge oxygen saturation (SpO(2)) recommendations (≥90% and ≥94%) in recovering bronchiolitis. METHODS AND PATIENTS: Infants aged up to 18 months requiring therapeutic oxygen for SpO(2) (≤93%) had SpO(2) assessed in air every 2 h. Time from admission to re-establish feeding (>75% normal) and for SpO(2) to become stable for at least 4 h at ≥90% and ≥94% were noted. RESULTS: 68 infants, median age 14 weeks, were included. Feeding problems resolved at a median of 11 h (inter-quartile range, IQR 0-47). SpO(2) became stable for at least 4 h at 17 h (IQR 0-49) for ≥90% and 63 h (IQR 34-105) for ≥94%. Time for infants to achieve a stable SpO(2)≥90% and resolve feeding difficulties was a median of 22 h (IQR 7-39 h) sooner than the equivalent for stable SpO(2)≥94%. CONCLUSIONS: Accepting lower SpO(2) at discharge could significantly reduce length of stay, but require the clinical and safety effects to be studied.
Authors: Christopher P Bonafide; Rui Xiao; Patrick W Brady; Christopher P Landrigan; Canita Brent; Courtney Benjamin Wolk; Amanda P Bettencourt; Lisa McLeod; Frances Barg; Rinad S Beidas; Amanda Schondelmeyer Journal: JAMA Date: 2020-04-21 Impact factor: 56.272
Authors: Mohamed A Hendaus; Suzan Nassar; Bassil A Leghrouz; Ahmed H Alhammadi; Mohammed Alamri Journal: Patient Prefer Adherence Date: 2018-04-03 Impact factor: 2.711
Authors: Brian LeCleir; Leslie Jurecko; Alan T Davis; Nicholas J Andersen; Dominic Sanfilippo; Surender Rajasekaran; Anthony Olivero Journal: Int J Pediatr Date: 2017-10-18
Authors: Steve Cunningham; Aryelly Rodriguez; Tim Adams; Kathleen A Boyd; Isabella Butcher; Beth Enderby; Morag MacLean; Jonathan McCormick; James Y Paton; Fiona Wee; Huw Thomas; Kay Riding; Steve W Turner; Chris Williams; Emma McIntosh; Steff C Lewis Journal: Lancet Date: 2015-09-12 Impact factor: 79.321